← Leaderboards
Justin S. Hanes
University Of Virginia
$23,093,683
Attributed
$35,747,262
Total exposure
23
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.3M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$35,747,262 · 23
By mechanism
R01$24,417,714 · 14
U19$4,641,556 · 1
R33$2,801,743 · 2
R21$1,788,218 · 4
U54$1,161,845 · 1
P01$936,186 · 1
Top collaborators
- Richard J Price13 shared
- Richard A Cone12 shared
- Laura Ensign10 shared
- Jung Soo Suk9 shared
- Anne Le5 shared
- Barbara Stauch Slusher5 shared
- Peter A Campochiaro4 shared
- Enid R Neptune1 shared
Most similar at University Of Virginia
Same institution · by research overlap
- Richard J Price$15,866,868
Others in their field
Top investigators on “Nanoparticle”
- David Heimbrook · Leidos Biomedical Research, Inc.$67,480,937
- Ralph Weissleder · Massachusetts General Hospital$52,944,531
- Robert J Hamers · University Of Wisconsin-Madison$40,936,500
- Gang Bao · Georgia Institute Of Technology$28,866,343
- Barton F Haynes · Duke University$28,645,614
- Bala Raja · Luminostics, Inc.$28,624,460
Research focus
NanoparticlePropertyParticleSurfaceBasePenetrationDoseMucous Body SubstancePharmaceutical PreparationsCellsTissuesToxic EffectDesignDrug KineticsDrug Delivery SystemsIn VivoSafetyLeadIn VitroAdhesivesDiffusionTechnologyFormulationEpithelium
Grant awards (82)
Topical drug delivery formulations for neuroprotection in glaucoma$537,385
R01 · FY2025 · EY
Eye drop formulations for enhanced penetration of water soluble antibiotics to treat infections$471,413
R01 · FY2025 · EY
Focused ultrasound pre-conditioning for augmented nanoparticle penetration in infiltrative gliomas$568,648
R01 · FY2024 · EB
Topical drug delivery formulations for neuroprotection in glaucoma$539,249
R01 · FY2024 · EY
Eye drop formulations for enhanced penetration of water soluble antibiotics to treat infections$471,413
R01 · FY2024 · EY
Focused ultrasound pre-conditioning for augmented nanoparticle penetration in infiltrative gliomas$583,441
R01 · FY2023 · EB
Eye drop formulations for enhanced penetration of water soluble antibiotics to treat infections$471,414
R01 · FY2023 · EY
Focused ultrasound pre-conditioning for augmented nanoparticle penetration in infiltrative gliomas$586,565
R01 · FY2022 · EB
Eye drop formulations for enhanced penetration of water soluble antibiotics to treat infections$471,413
R01 · FY2022 · EY
Focused ultrasound pre-conditioning for augmented nanoparticle penetration in infiltrative gliomas$606,239
R01 · FY2021 · EB
Targeted Delivery of Brain Penetrating DNA Nanoparticles to Brain Tumors$504,105
R01 · FY2020 · CA · contact PI
Glutaminase Inhibitor Drug Discovery and Nanoparticle-Based Delivery for Pancreatic Cancer Therapy$417,346
R01 · FY2020 · CA
Targeted Delivery of Brain Penetrating DNA Nanoparticles to Brain Tumors$488,981
R01 · FY2019 · CA · contact PI
Glutaminase Inhibitor Drug Discovery and Nanoparticle-Based Delivery for Pancreatic Cancer Therapy$406,798
R01 · FY2019 · CA
Mucus-Penetrating Nanoparticle Containing Enemas for Ulcerative Colitis$364,500
R01 · FY2019 · DK
Pre-clinical progressive selection of a tenofovir analog enema$670,178
U19 · FY2018 · AI · contact PI
MRI-Guided miRNA Nanoparticle Delivery to Glioblastoma With Focused Ultrasound$612,150
R01 · FY2018 · EB
Targeted Delivery of Brain Penetrating DNA Nanoparticles to Brain Tumors$506,098
R01 · FY2018 · CA · contact PI
Glutaminase Inhibitor Drug Discovery and Nanoparticle-Based Delivery for Pancreatic Cancer Therapy$425,618
R01 · FY2018 · CA
Biomaterial Inhibitor of HIF-1 for Prolonged Anti-Angiogenesis in Eye$422,481
R01 · FY2018 · EB · contact PI
Biodegradable Mucus Penetrating DNA Nanoparticle for Gene Therapy of CF$396,283
R01 · FY2018 · HL · contact PI
Mucus-Penetrating Nanoparticle Containing Enemas for Ulcerative Colitis$364,500
R01 · FY2018 · DK
Pre-clinical progressive selection of a tenofovir analog enema$1,062,037
U19 · FY2017 · AI · contact PI
MRI-Guided miRNA Nanoparticle Delivery to Glioblastoma With Focused Ultrasound$600,000
R01 · FY2017 · EB
Targeted Delivery of Brain Penetrating DNA Nanoparticles to Brain Tumors$512,053
R01 · FY2017 · CA · contact PI
Glutaminase Inhibitor Drug Discovery and Nanoparticle-Based Delivery for Pancreatic Cancer Therapy$425,618
R01 · FY2017 · CA
Biomaterial Inhibitor of HIF-1 for Prolonged Anti-Angiogenesis in Eye$422,481
R01 · FY2017 · EB · contact PI
Biodegradable Mucus Penetrating DNA Nanoparticle for Gene Therapy of CF$396,404
R01 · FY2017 · HL · contact PI
Mucus-Penetrating Nanoparticle Containing Enemas for Ulcerative Colitis$364,500
R01 · FY2017 · DK
Pre-clinical progressive selection of a tenofovir analog enema$940,730
U19 · FY2016 · AI · contact PI
MRI-Guided miRNA Nanoparticle Delivery to Glioblastoma With Focused Ultrasound$604,239
R01 · FY2016 · EB
Brain Tumor-Penetrating Nanoparticle Delivery with MR-Guided Focused Ultrasound$595,674
R01 · FY2016 · CA
Targeted Delivery of Brain Penetrating DNA Nanoparticles to Brain Tumors$527,553
R01 · FY2016 · CA · contact PI
Glutaminase Inhibitor Drug Discovery and Nanoparticle-Based Delivery for Pancreatic Cancer Therapy$425,618
R01 · FY2016 · CA
Biomaterial Inhibitor of HIF-1 for Prolonged Anti-Angiogenesis in Eye$422,481
R01 · FY2016 · EB · contact PI
Biodegradable Mucus Penetrating DNA Nanoparticle for Gene Therapy of CF$396,524
R01 · FY2016 · HL · contact PI
Mucus-Penetrating Nanoparticle Containing Enemas for Ulcerative Colitis$364,500
R01 · FY2016 · DK
Pre-clinical progressive selection of a tenofovir analog enema$967,691
U19 · FY2015 · AI · contact PI
MRI-Guided miRNA Nanoparticle Delivery to Glioblastoma With Focused Ultrasound$626,441
R01 · FY2015 · EB
Brain Tumor-Penetrating Nanoparticle Delivery with MR-Guided Focused Ultrasound$608,149
R01 · FY2015 · CA
Mucus Penetrating Particles for Rectal Microbicides$464,117
R33 · FY2015 · AI · contact PI
Mucus Microstructure and Osmotic Pressure: Biomarkers for CB in COPD$449,417
R01 · FY2015 · HL
Biomaterial Inhibitor of HIF-1 for Prolonged Anti-Angiogenesis in Eye$422,481
R01 · FY2015 · EB · contact PI
Biodegradable Mucus Penetrating DNA Nanoparticle for Gene Therapy of CF$412,141
R01 · FY2015 · HL · contact PI
Pre-clinical progressive selection of a tenofovir analog enema$1,000,920
U19 · FY2014 · AI · contact PI
Brain Tumor-Penetrating Nanoparticle Delivery with MR-Guided Focused Ultrasound$600,359
R01 · FY2014 · CA
Mucus Penetrating Particles for Rectal Microbicides$472,556
R33 · FY2014 · AI · contact PI
Pathogen trapping by genital mucus secretions$317,540
R01 · FY2014 · HD · contact PI
Mucus Penetrating Nanoparticles for Small Cell Lung Cancer$179,452
U54 · FY2014 · CA · contact PI
Brain Tumor-Penetrating Nanoparticle Delivery with MR-Guided Focused Ultrasound$592,826
R01 · FY2013 · CA
Mucus Penetrating Particles for Rectal Microbicides$451,874
R33 · FY2013 · AI · contact PI
Pathogen trapping by genital mucus secretions$310,027
R01 · FY2013 · HD · contact PI
Mucus Penetrating Nanoparticles for Small Cell Lung Cancer$285,845
U54 · FY2013 · CA · contact PI
New approaches to overcome the sputum barrier to gene delivery$176,030
P01 · FY2013 · HL · contact PI
Brain Tumor-Penetrating Nanoparticle Delivery with MR-Guided Focused Ultrasound$721,309
R01 · FY2012 · CA
Mucus-penetrating nanoparticles for sustained microbicide delivery$455,632
R33 · FY2012 · AI · contact PI
Pathogen trapping by genital mucus secretions$326,688
R01 · FY2012 · HD · contact PI
Mucus Penetrating Nanoparticles for Small Cell Lung Cancer$278,437
U54 · FY2012 · CA · contact PI
Mucus Penetrating Particles for Rectal Microbicides$240,689
R21 · FY2012 · AI · contact PI
New approaches to overcome the sputum barrier to gene delivery$185,697
P01 · FY2012 · HL · contact PI
Mucus-penetrating nanoparticles for sustained microbicide delivery$467,744
R33 · FY2011 · AI · contact PI
Pathogen trapping by genital mucus secretions$326,688
R01 · FY2011 · HD · contact PI
Mucus Penetrating Nanoparticles for Small Cell Lung Cancer$203,247
U54 · FY2011 · CA · contact PI
Mucus Penetrating Particles for Rectal Microbicides$199,793
R21 · FY2011 · AI · contact PI
New approaches to overcome the sputum barrier to gene delivery$189,885
P01 · FY2011 · HL · contact PI
Mucus-penetrating nanoparticles for sustained microbicide delivery$489,820
R33 · FY2010 · AI · contact PI
New Gene Vectors for Cystic Fibrosis (CF): Extra- & Intracellular Barriers$352,376
R01 · FY2010 · EB · contact PI
Pathogen trapping by genital mucus secretions$340,300
R01 · FY2010 · HD · contact PI
Mucus penetrating nanoparticles for early stage cervical cancer$340,298
R01 · FY2010 · CA · contact PI
Mucus Penetrating Nanoparticles for Small Cell Lung Cancer$214,864
U54 · FY2010 · CA · contact PI
New approaches to overcome the sputum barrier to gene delivery$190,637
P01 · FY2010 · HL · contact PI
New Gene Vectors for Cystic Fibrosis (CF): Extra- & Intracellular Barriers$356,474
R01 · FY2009 · EB · contact PI
Mucus penetrating nanoparticles for early stage cervical cancer$324,362
R01 · FY2009 · CA · contact PI
Polymer nanoparticles that cross mucus$245,000
R21 · FY2009 · HL · contact PI
Mucus Penetrating Nanoparticles for Vaginal Drug Delivery$244,932
R21 · FY2009 · EB · contact PI
Mucus-penetrating nanoparticles for sustained microbicide delivery$244,745
R21 · FY2009 · AI · contact PI
New approaches to overcome the sputum barrier to gene delivery$193,937
P01 · FY2009 · HL · contact PI
New Gene Vectors for Cystic Fibrosis (CF): Extra- & Intracellular Barriers$356,988
R01 · FY2008 · EB · contact PI
Mucus-penetrating nanoparticles for sustained microbicide delivery$205,000
R21 · FY2008 · AI · contact PI
Polymer nanoparticles that cross mucus$204,048
R21 · FY2008 · HL · contact PI
Mucus Penetrating Nanoparticles for Vaginal Drug Delivery$204,011
R21 · FY2008 · EB · contact PI
New Gene Vectors for Cystic Fibrosis (CF): Extra- & Intracellular Barriers$359,165
R01 · FY2007 · EB · contact PI